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Global	overview	and	highlights
N	>	115,000
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Country	breakdown	of	respondents	by	country	(to	the	nearest	50)
Country	 n Country	 n
Germany 36000 Greece 1600
Denmark 13500 Mexico 1350
USA 10100 Colombia 1050
Switzerland 7850 Portugal 900
UK 5900 Belgium 800
Australia 5750 Norway 550
Canada 5400 France 500
Austria 4850 Spain 500
New	Zealand 3800 Sweden 500
Italy 3500 Ireland 500
Netherlands 3250 Poland 450
Brazil 3000 Finland 400
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DRUG	USE	AMONG	THE	SAMPLE
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Global	comparison of emergency medical treatment seeking – GDS2017	all	substances
N	users	12m:	>1,400								 >1200 >100,000																				>20,000																						>11,000 >20,000																						>10,000																				>60,000 >	10,000
4.8
3.2



























Methamphetamine Synth.	cannabis	 Alcohol MDMA/Ecstacy Amphetamine Cocaine	 LSD Cannabis Magic	mushrooms	
Global	(M+F) Male Female
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Selected	data	presented	here	comes	from	the	section	that	includes
A	total	of	114,039 drinkers	participated	in	GDS2017	and	were	used	in	the	preparation	of	the	this	report.





















Male	<25 Male	25	+ Female	<25 Female	25	+
AUDIT	Scores	by	age	and	gender	(%)
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Alcohol	users	that	aim	to	drink	less	next	year	&	help	seeking	behavior
47.0 46.3 46.1 44.7 44.3 43.0 42.8
41.0 40.4 40.3 39.1 39.0
37.4 37.1 36.9 36.5 35.8 34.7 33.9 33.5 33.5 33.4 32.9
31.0 30.0
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Selected	data	presented	here	comes	from	the	section	that	includes
A	total	of	69,299 cannabis	users	participated	in	GDS2017	and	were	used	in	the	preparation	of	the	this	report.
































1 2-10	 11-50	 51-100	
101-200 201-300	 300+	
Mean	number	of	days	=	135.4 Mean	number	of	days	=	144.5 Mean	number	of	days	=	110.2
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Global	comparison – who uses tobacco with their cannabis
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Cannabis	users	who	aim	to	use	less	cannabis	next	year	&	help	seeking	behavior
44.0
37.6 37.4 37.2 37.2 36.9 36.4 36.2 36.2
33.9 32.9 32.4 32.0 31.7 31.7 31.5 31.4 31.3 30.9 29.8 29.6 29.5







































































GDS2014 GDS2015 GDS2016 GDS2017
?













































Global Drug Survey GDS2017 © Not to be reproduced without authors permission
Selected	data	presented	here	comes	from	the	section	that	includes
A	total	of	8,500	recent	cannabis	users	were	included	in	the	preparation	of	this	section	of	the	report.
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Synthetic	cannabinoids	(SCRAs)	– Global























































































































Herbal Powder Resin Oil missing
Vaping	– Global
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Selected	data	presented	here	comes	from	the	section	that	includes
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1 2-10	 11-50	 51-100	 100+	
Mean	number	of	days	=	16 Mean	number	of	days	=	16 Mean	number	of	days	=	16
Global	cocaine	data
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60.2 58.6
55.7 55.7
51.2 50.0 48.1 47.1 46.4
43.6
40.7 39.3 39.1 38.5 37.9
35.9 34.9 34.9 34.7
32.1
29.3 28.6
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Average	number of days of ecstasy (MDMA)	use in	the last	12	months by country
*n=23,174	last	year users
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Main	method of MDMA	use =	swallow a	pill/	capsule containing MDMA	(see our blog





54.3% 53.9% 53.0% 52.8% 
49.8% 
48.9% 
47.4% 46.9% 45.8% 45.7% 44.4% 42.1% 42.1% 
37.3% 






Did you seek any information (content/purity)	on	the pill/powder you were using before using
MDMA	in	the last	12	months?	
Only one in	ten recent MDMA	users reported the direct or indirect
use of drug checking services to determine the content and	purity
of their drugs used.	The	low numbers are mainly due	to a	lack	of
drug checking services in	most countries	and	higher service use
prevalence among users can be found in	countries	where drug
checking is legally available,	such	as Switzerland and	Austria.
*n=>	16,500	last	year users
8.5% 
12.3% 11.8% 11.2% 11.6% 12.7% 10.1% 11.0% 11.0% 8.3% 













Female	<25 Male	<25 All Female	25	+ Male	25	+ 
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1.1% 1.2% 1.2% 
0.7% 
Female	<25	(n=3,529) Male	<25	(n=8,734) All	(n=20,837) Female	25	+	(n=2,284) Male	25	+	(n=6,290) 
In	total,	250participants	reported seeking EMT	
following the use of MDMA.	Young	women were
significantly more likely to report having sought
emergency medical treatment following the use of
MDMA.
*n=	>20,000	last	year users



















































































8)	Plan	a	break	of a	few months and	remember people can have wicked nights out	without a	pill
9)	Think	about why you are using – if pills are being used to solve problems – find	another way
10)Think	about	what	else	you	might	be	doing	better	if	you	cut	back	– maybe	better	relationships/	work/	health?	
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10	ways to go about using less MDMA	this year if you want to use a	bit less























































Snort Smoke Oral	 Inject Rectal Other
%	methamphetamine %	amphetamine	powder	 %	amphetamine	base

































































































Ketamine Nitrous	Oxide LSD Magic	mushrooms 2-CB DMT LSD	analogues
Chart	Title
GDS2014 GDS2015 GDS2016 GDS2017
86
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Where,	and	age	of	first	use	of	LSD	(global	sample)















































































































































þ The	%	of users who have already travelled to another country for such	a	„retreat“.









































































































that their dosing was	guess work – that is trial and	error using farctions of LSD	tabs bought from a	dealer or on	darknet
markets.	Please note that the psychedelics part of the GDS	mini	survey was	announced in	the newspaper and	that this is
not	a	prevalence estimates,	but	rather a	description of the sample	reached.























þ Which	drug	types	and	how	many	different	types	have	you	obtained	from	darknet markets?	– global	3-yr	trends
þ What	proportion	of	these	drugs	purchased	through	darknet vendors	in	your	own	country	or	from	abroad?	– global	
2017	and	by	country































































































































































































Croatia 119Base	sample:	Last year	use	of	 illicit	drugs,	new	psychoactive	substances	and/or	prescription	drugs*	Includes	those	who	report	personally purchasing	drugs,	arranging	for	others	to	purchase	drugs	or	purchasing	on	behalf	of	others	from	darknet	markets.
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Background
• GDS has been tracking the use of ‘Novel Psychoactive Substances’ legal highs’, ‘research chemicals’ for the last 5 
years.
• While there may be many new substances identified each week just because drugs are available on line or in ‘head 
shops’ it does mean they are being used. 
• Overall there was increase in the percentage of Global GDS respondents  who reported purchasing NPS in the last 
12 months from 4.2% to 4.8%, with many countries seeing a notable increase in use. 
• GDS thinks where people have good access to good quality traditional drugs the interest in NPS is generally low 
(for example in Switzerland). The Desert Island Drugs section and motivations for use will expand on this 
hypothesis
• The reduction in last year use in countries such as New Zealand suggests closing ‘head shops’ might lead to 
reduced sales a point that is of importance given that there appears to have been an increase in the proportion of 
GDS respondents globally of people buying from shops – though this show marked regional variation. 
• There also seems to have been increase in the use of pills and powders compared to smoking mixtures though 






Conversely	despite	ready	availability	of	other	traditi n l	drugs	they	report	one	of	highest	rates	of	 PS	use	among	the	
GDS	sa ple.	
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Herbal Powder	/	Crystal Tablet	/	pills Liquids
GDS2017	 GDS2016	 GDS2015	
%








































































































































































Global Drug Survey GDS2017 © Not to be reproduced without authors permission
Background	
Key	results	presented	in	this	section






























Italy UK Australia USA Global Canada Mexico New	
Zealand
SwitzerlandNetherlands Germany Austria Brazil
Pr
op
or
tio
n	
of
	u
se
rs
	re
po
rt
in
g	
sn
iff
er
	d
og
	e
nc
ou
nt
er
s	
in
	la
st
	1
2	
m
on
th
s	
(%
)
We	hope	you	enjoyed	this	report	
which	we	gladly	share	with	
you	with	for	free.	If	you	like	what	
Global	Drug	Survey	does
then	we’d	like	to	ask	
you	to	make	the	smallest	of	
donations	– the	price	of	joint,	a	pill,	a	line,	a	beer.	
Your	donation	will	help	us	carry	on	being	independent,	run	the	survey	and	
encourage	governments,	communities	and	people	to	have	honest	
conversations	about	drugs.	
Was	this	interesting?	
If	you	would	like	to	get	your	country	or	region	involved	in	GDS2018	
please	e	mail	us	at	info@globaldrugsurvey.com
